Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone
Go back to Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 82.41 -0.22 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.63 | 52 Week High | $8.22 | |||
| Open | $81.58 | 52 Week Low | $3.07 | |||
| Day High | $83.38 | P/E | N/A | |||
| Day Low | $80.33 | EPS | $-1.30 | |||
| Volume | 222,963 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.76 -1.26 (5.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.02 | 52 Week High | $63.73 | |||
| Open | $22.02 | 52 Week Low | $8.00 | |||
| Day High | $22.02 | P/E | N/A | |||
| Day Low | $20.74 | EPS | $-5.69 | |||
| Volume | 596,874 | |||||
